fomesafen has been researched along with Liver Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chlumská, A; Fakan, F; Kocová, L; Krijt, J | 1 |
| Aghemo, A; Akarca, US; Al Masri, NM; Al-Hamoudi, WK; Alalwan, AM; Aleman, S; Alghamdi, AS; Alghamdi, S; Aljumah, AA; Altraif, IH; Asselah, T; Ben-Ari, Z; Berg, T; Biondi, MJ; Blach, S; Braga, WSM; Brandão-Mello, CE; Brunetto, MR; Buti, M; Cabezas, J; Cheinquer, H; Chen, PJ; Cheon, ME; Chuang, WL; Coffin, CS; Coppola, N; Craxi, A; Crespo, J; De Ledinghen, V; Duberg, AS; Etzion, O; Ferraz, MLG; Ferreira, PRA; Forns, X; Foster, GR; Gaeta, GB; Gamkrelidze, I; García-Samaniego, J; Gheorghe, LS; Gholam, PM; Gish, RG; Glenn, J; Hercun, J; Hsu, YC; Hu, CC; Huang, JF; Janjua, N; Jia, J; Kåberg, M; Kaita, KDE; Kamal, H; Kao, JH; Kondili, LA; Lagging, M; Lázaro, P; Lazarus, JV; Lee, MH; Lim, YS; Marotta, PJ; Navas, MC; Naveira, MCM; Orrego, M; Osiowy, C; Pan, CQ; Pessoa, MG; Raimondo, G; Ramji, A; Razavi, HA; Razavi-Shearer, DM; Razavi-Shearer, K; Ríos-Hincapié, CY; Rodríguez, M; Rosenberg, WMC; Roulot, DM; Ryder, SD; Safadi, R; Sanai, FM; Santantonio, TA; Sarrazin, C; Shouval, D; Tacke, F; Tanaka, J; Tergast, TL; Terrault, NA; Villalobos-Salcedo, JM; Voeller, AS; Yang, HI; Yu, ML; Yurdaydin, C; Zeuzem, S; Zuckerman, E | 1 |
| Buti, M; Casado, MÁ; Domínguez-Hernández, R; Esteban, R; Palom, A | 1 |
| Ampuero, J; Fernández Rodríguez, CM; Herrero, JI | 1 |
4 other study(ies) available for fomesafen and Liver Neoplasms
| Article | Year |
|---|---|
Cytoplasmic liver cell inclusions--a typical feature of porphyria cutanea tarda--are absent in porphyria-related hepatic neoplasias.
Topics: Animals; Benzamides; Carcinoma, Hepatocellular; Herbicides; Humans; Inclusion Bodies; Infant; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred ICR; Middle Aged; Porphyria Cutanea Tarda | 1998 |
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
Topics: Coinfection; Hepatitis Antibodies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Liver Neoplasms; Prevalence; Reflex; RNA | 2023 |
Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis.
Topics: Carcinoma, Hepatocellular; Hepatitis Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Liver Neoplasms; Reflex; RNA | 2023 |
Reflex testing. A key tool for the elimination of hepatitis C.
Topics: Antiviral Agents; Hepatitis C; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Reflex | 2020 |